sydney meeting, page-21

Thanks for sharing the info. This must be the most expensive way to update shareholders with a handful in Melbourne and Sydney. It is our money these guys are spending on shareholders tea parties - a sobering reflection of PC's idea of managing shareholders value!

You are relying on Peter Cook's legendary skill in creating shareholders value, look at the OEC share price performance when PC was the CEO. His skill is also reflected when he rejected the $100m GSK settlement offer and accepting a $20m offer after burning $30m in legal costs.
Why do you think PC can perform in getting Biota shareholders good value for a take over/merger/ call it what you like deal to go to NASDAQ?


It is a joke PC was implying generic Tamiflu will be the serious competitor to LANI. Remember Relenza patents run out long before Tamiflu. Peter Cook did nothing to advance LANI trial in ROW for the 5 years he is CEO, as a result there is this huge gap between Relanza patents expiring and LANI going into the market.
Is this Peter Cook's way of "smoothing" Biota income stream.